Mercer Global Advisors
EHC icon

Mercer Global Advisors’s Encompass Health EHC Stock Holding History

Mercer Global Advisors’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.59M Buy
15,728
+2,092
+15% +$217K ﹤0.01% 1480
2026
Q1 		$1.32M Sell
13,636
-1,510
-10% -$155K ﹤0.01% 1422
2025
Q4 		$1.61M Sell
15,146
-3,466
-19% -$402K ﹤0.01% 1219
2025
Q3 		$2.36M Buy
18,612
+690
+4% +$82.1K ﹤0.01% 966
2025
Q2 		$2.2M Buy
17,922
+306
+2% +$34.9K ﹤0.01% 844
2025
Q1 		$1.78M Buy
17,616
+164
+0.9% +$16K ﹤0.01% 878
2024
Q4 		$1.61M Buy
17,452
+749
+4% +$73.5K ﹤0.01% 898
2024
Q3 		$1.6M Buy
16,703
+287
+2% +$25.8K ﹤0.01% 838
2024
Q2 		$1.41M Buy
16,416
+5,049
+44% +$424K ﹤0.01% 826
2024
Q1 		$939K Buy
11,367
+1,319
+13% +$96.6K ﹤0.01% 989
2023
Q4 		$670K Buy
10,048
+795
+9% +$51.5K ﹤0.01% 1159
2023
Q3 		$621K Buy
9,253
+4,632
+100% +$319K ﹤0.01% 1144
2023
Q2 		$313K Sell
4,621
-3,878
-46% -$243K ﹤0.01% 1492
2023
Q1 		$460K Sell
8,499
-1,210
-12% -$70.4K ﹤0.01% 1252
2022
Q4 		$581K Buy
9,709
+852
+10% +$46.3K ﹤0.01% 1131
2022
Q3 		$401K Sell
8,857
-2,095
-19% -$105K ﹤0.01% 1241
2022
Q2 		$488K Sell
10,952
-514
-4% -$26.4K ﹤0.01% 1158
2022
Q1 		$649K Sell
11,466
-59,805
-84% -$3.12M ﹤0.01% 1100
2021
Q4 		$3.7M Sell
71,271
-655
-0.9% -$33.8K 0.02% 444
2021
Q3 		$4.29M Sell
71,926
-248
-0.3% -$15.6K 0.03% 387
2021
Q2 		$4.48M Buy
72,174
+478
+0.7% +$31.9K 0.03% 345
2021
Q1 		$4.67M Sell
71,696
-286
-0.4% -$18.7K 0.04% 308
2020
Q4 		$4.74M Sell
71,982
-140
-0.2% -$8.24K 0.06% 238
2020
Q3 		$3.73M Sell
72,122
-731
-1% -$37.5K 0.06% 246
2020
Q2 		$3.59M Sell
72,853
-45
-0.1% -$2.43K 0.07% 214
2020
Q1 		$3.71M Sell
72,898
-44
-0.1% -$2.54K 0.08% 201
2019
Q4 		$4.02M Buy
72,942
+717
+1% +$38.9K 0.08% 209
2019
Q3 		$3.63M Buy
72,225
+546
+0.8% +$27.4K 0.09% 190
2019
Q2 		$3.61M Buy
71,679
+133
+0.2% +$6.46K 0.1% 175
2019
Q1 		$3.32M Buy
+71,546
New +$3.62M 0.12% 150

Other funds holding EHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Mercer Global Advisors's EHC Position: Q2 2026 in Review

Mercer Global Advisors increased its Encompass Health (EHC) stake by 15% in Q2 2026, buying an estimated $217K and bringing the position to 15,728 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1480.

Mercer Global Advisors first reported a position in EHC in Q1 2019 and has held it in 30 quarters since. The position peaked at $4.74M in Q4 2020. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Mercer Global Advisors held 15,728 shares of Encompass Health worth $1.59M as of Q2 2026.
  • Mercer Global Advisors bought 2,092 Encompass Health shares in Q2 2026, an estimated $217K.
  • Encompass Health made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #1480 holding.
  • Mercer Global Advisors first reported a position in Encompass Health in Q1 2019 and has held it in 30 quarters since.
  • Mercer Global Advisors's Encompass Health position peaked at $4.74M in Q4 2020.
  • 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.